STNM1 in human cancers: role, function and potential therapy sensitizer

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• Stathmin (STMN1) is a key microtubule-associated protein (MAP) regulating microtubule dynamics.
• STMN1 expression is frequently upregulated in various human malignancies.
• Understanding STMN1's role is critical for advancing cancer therapy.

Purpose of the Study:

• To summarize the characteristics of STMN1.
• To elucidate STMN1's mechanisms in cancer development and progression.
• To review STMN1's role in tumor resistance and its potential as a therapeutic target.

Main Methods:

• Literature review and synthesis of existing research on STMN1.
• Analysis of STMN1's interactions with signaling networks.
• Examination of STMN1's regulation by non-coding RNAs (microRNAs, circRNAs, lincRNAs).

Main Results:

• STMN1 destabilizes microtubules, influencing cell cycle arrest at the G2/M phase.
• STMN1 expression affects tumor cell sensitivity to anti-microtubule chemotherapy agents.
• STMN1 is implicated in multiple cancer signaling pathways and is regulated by various ncRNAs.

Conclusions:

• STMN1 is a significant factor in cancer development, progression, and therapeutic resistance.
• Targeting STMN1 holds promise for novel cancer treatment strategies.
• Further research into STMN1 mechanisms is essential for effective clinical application.